Clinical Study

Summary

To examine antihypertensive effect and safety of CS-3150 in patients with primary aldosteronism.

Study Name: Study of CS-3150 in Patients With Primary Aldosteronism
Status: Completed
Conditions: Primary aldosteronism
Interventions: Drug: CS-3150
Locations: Japan Organaization of Occupational Health and Safety(JOHAS), Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan
Study link: https://ClinicalTrials.gov/show/NCT02885662

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.